Overview Financials News + Filings Key Docs Charts Ownership Insiders |
DermTech, Inc. (CNAC)
|
Add to portfolio |
|
|
Price: |
$16.35
| | Metrics |
OS: |
33.7
|
M
| |
|
|
Market cap: |
$551
|
M
| |
|
|
Net cash:
|
$86.2
|
M
| |
$2.56
|
per share
|
EV:
|
$464
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
|
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Mar-31-19 | Dec-31-18 | Mar-31-18 | Dec-31-17 |
Revenues | 14.5 | 11.8 | 5.9 | 3.4 | 0.0 | 2.4 | 0.0 | 1.7 |
Revenue growth | 22.6% | 101.2% | 74.9% | 37.8% | | 42.1% | | |
Cost of goods sold | 13.9 | 10.6 | 6.0 | 3.3 | 0.0 | 2.6 | 0.0 | 2.6 |
Gross profit | 0.6 | 1.3 | -0.1 | 0.1 | 0.0 | -0.2 | 0.0 | -0.9 |
Gross margin | 4.5% | 10.8% | -1.6% | 1.8% | | -7.6% | | -49.7% |
Selling, general and administrative | | | | | 2.0 | | 0.3 | |
Sales and marketing | 58.7 | 37.6 | 16.1 | 6.3 | | 2.8 | | 2.9 |
Research and development | 24.1 | 16.3 | 5.3 | 2.5 | | 2.1 | | 2.0 |
General and administrative | 36.1 | 24.8 | 13.8 | 8.9 | | 3.5 | | 2.6 |
EBIT | -118.2 | -77.4 | -35.3 | -17.6 | -2.0 | -8.6 | -0.3 | -8.4 |
EBIT margin | -813.9% | -653.8% | -599.6% | -523.3% | | -350.5% | | -486.1% |
Pre-tax income | -116.7 | -78.3 | -36.5 | -20.1 | 0.9 | -10.0 | 0.9 | 0.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
Net income | -116.7 | -78.3 | -36.5 | -20.1 | 0.9 | -10.0 | 0.9 | 0.0 |
Net margin | -803.7% | -661.7% | -619.8% | -598.4% | | -409.7% | | 0.0% |
|
Diluted EPS | ($3.88) | ($2.71) | ($2.15) | ($2.87) | $0.18 | ($2.27) | $0.18 | $0.00 |
Shares outstanding (diluted) | 30.0 | 28.9 | 17.0 | 7.0 | 5.1 | 4.4 | 4.7 | 4,407.1 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|